Skip to content

Milli-fire needle for pruritus of neurodermatitis----A randomized clinical trial

Milli-fire needle for pruritus of neurodermatitis----A randomized clinical trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005567
Enrollment
Unknown
Registered
2022-01-31
Start date
2022-01-31
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurodermatitis

Interventions

treatment group:Milli-fire needle

Sponsors

Guang 'anmen Hospital, China Academy of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Meet the above diagnostic criteria of Traditional Chinese and western medicine; ? (2) Patients aged 18-65 years, with no gender limitation, and the course of disease =6 weeks; ? (3) The total skin area shall not exceed 10% of the body surface; (4) Pruritus peak value scale (PP-NRS)=4; (5) Clear mind, able to understand the scale content and cooperate with treatment, willing to participate in this study, and sign informed consent. Only those who meet the above five criteria can be included in the study.

Exclusion criteria

Exclusion criteria: (1) patients who have used glucocorticoids and calcineurin inhibitors within and outside 2 weeks; (2) oral glucocorticoids and antihistamines within 2 weeks; (3) patients with serious diseases of heart, lung, brain, liver, kidney and hematopoietic system, mental diseases and cognitive dysfunction; (4) women who plan to become pregnant during pregnancy, lactation or within the last 8 months; (5) skin lesions on the face and eyelids; (6) scar constitution; (7) Infection, damage and erosion at the lesion; (8) Allergy, contraindication or intolerance to halometasone ointment; (9) Those who refuse to take hormone drug treatment or refuse to accept fire needle treatment. Those who met any one of the above criteria were excluded from the study.

Design outcomes

Primary

MeasureTime frame
PeakPruritus Numerical Rating Scale;

Countries

China

Contacts

Public ContactGuo Yufeng
gamgyf@139.com18511664134

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026